Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration

被引：0
作者：
Gerardo Aguilar
Rafael Ferriols
Sara Martínez-Castro
Carlos Ezquer
Ernesto Pastor
José A. Carbonell
Manuel Alós
David Navarro
机构：
[1] Hospital Clínico Universitario de Valencia,Critical Care Unit, Anesthesiology and Critical Care Department
[2] INCLIVA Health Research Institute,Department of Pharmacy
[3] Hospital Clínico Universitario de Valencia,Department of Microbiology
[4] Hospital Clínico Universitario de Valencia,undefined
[5] School of Medicine,undefined
[6] University of Valencia,undefined
来源：
Critical Care | / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 20 条
  • [1] Montravers P(2018)The ideal patient profile for new beta-lactam/beta-lactamase inhibitors Curr Opin Infect Dis 31 587-e93
  • [2] Bassetti M(2015)Ceftolozane-tazobactam pharmacokinetics in a critically ill patient on continuous venovenous hemofiltration Antimicrob Agents Chemother 60 1899-1901
  • [3] Oliver WD(2016)Treatment of multidrug-resistant Pseudomonas aeruginosa with ceftolozane/tazobactam in a critically ill patient receiving continuous venovenous haemodiafiltration Int J Antimicrob Agents 48 342-343
  • [4] Heil EL(2016)Ceftolozane/tazobactam pharmacokinetics in a critically ill adult receiving continuous renal replacement therapy Pharmacotherapy 36 e30-ee3
  • [5] Gonzales JP(undefined)undefined undefined undefined undefined-undefined
  • [6] Mehrotra S(undefined)undefined undefined undefined undefined-undefined
  • [7] Robinett K(undefined)undefined undefined undefined undefined-undefined
  • [8] Saleeb P(undefined)undefined undefined undefined undefined-undefined
  • [9] Nicolau DP(undefined)undefined undefined undefined undefined-undefined
  • [10] Kuti JL(undefined)undefined undefined undefined undefined-undefined
12